Ethan A. Skerry

212-430-2670
eskerry@fenwick.com
Partner
Corporate

Ethan A.
Skerry

Ethan A.
Skerry

Ethan A.
Skerry

Partner
Corporate

Ethan is a leading technology and life sciences M&A lawyer who has completed hundreds of transactions across a wide range of industries, including software, gaming, e-commerce, artificial intelligence, social networking and life sciences. Ethan represents both public and private companies on acquisitions, sales and other complex strategic and financing transactions. Ethan also acts as an outside advisor to industry disrupting technology and life sciences companies on corporate governance and other matters, and regularly represents venture capital and private equity investors in investments.

Ethan’s work has been consistently recognized by leading legal publications, such as Chambers USA, The Legal 500, Super Lawyers and The BTI Consulting Group.

Ethan currently serves as a member of Fenwick’s compensation committee, and previously served as a member of the firm’s executive committee. He is resident in Fenwick’s New York office.

Ethan "has a strong knowledge base and amazing negotiation skills. He finds viable solutions to efficiently navigate extremely complex transactions."

Chambers USA, Client Quote

2021 Edition

  • Databricks in numerous acquisitions, including its acquisition of Mosaic ML
  • Clear in multiple acquisitions
  • Yuga Labs in its acquisition of WENEW
  • OrderGroove in its recapitalization led by Primus Capital
  • Muck Rack in its growth financing led by Susquehanna Growth Equity
  • Molekule in its merger with Aeroclear
  • Billie in its sale to Edgewell Personal Care
  • Nextdoor in its de-SPAC merger with Khosla Ventures Acquisition Co. II
  • Buzzfeed in its de-SPAC merger with 890 Fifth Avenue Partners SPAC and in its acquisition of Complex Networks
  • Peloton in multiple acquisition transactions, including its acquisition of Precor
  • SADA in its sale to Insight Enterprises
  • Stripe in its acquisitions of Paystack and TaxJar
  • ThousandEyes in its acquisition by Cisco
  • Seal Software in its acquisition by DocuSign
  • DocuSign in its acquisition of LiveOak
  • eSilicon in the divestiture of certain assets to Synopsys and sale to Inphi
  • SignalFX in its $1.05B sale to Splunk
  • Mphasis in multiple acquisitions
  • Delphi in its acquisition of nuTonomy

  • Databricks in numerous acquisitions, including its acquisition of Mosaic ML
  • Clear in multiple acquisitions
  • Yuga Labs in its acquisition of WENEW
  • OrderGroove in its recapitalization led by Primus Capital
  • Muck Rack in its growth financing led by Susquehanna Growth Equity
  • Molekule in its merger with Aeroclear
  • Billie in its sale to Edgewell Personal Care
  • Nextdoor in its de-SPAC merger with Khosla Ventures Acquisition Co. II
  • Buzzfeed in its de-SPAC merger with 890 Fifth Avenue Partners SPAC and in its acquisition of Complex Networks
  • Peloton in multiple acquisition transactions, including its acquisition of Precor
  • SADA in its sale to Insight Enterprises
  • Stripe in its acquisitions of Paystack and TaxJar
  • ThousandEyes in its acquisition by Cisco
  • Seal Software in its acquisition by DocuSign
  • DocuSign in its acquisition of LiveOak
  • eSilicon in the divestiture of certain assets to Synopsys and sale to Inphi
  • SignalFX in its $1.05B sale to Splunk
  • Mphasis in multiple acquisitions
  • Delphi in its acquisition of nuTonomy

  • SomaLogic in its merger with Standard BioTools
  • Pardes in its going private transaction
  • Aceragen in its merger with Idera Pharmaceuticals
  • Market Access Transformation in its sale to Genesis Research
  • Klara Health in its sale to Modernizing Medicine
  • CareSignal in its sale to Lightbeam Health Solutions
  • PlushCare in its acquisition by Accolade
  • Sema4 in its acquisition of GeneDx and its de-SPAC merger with CM Life Sciences
  • ZipDrug in its acquisition by Anthem Health
  • Chinook Therapeutics in its merger with Aduro Biotech
  • Mavupharma in its acquisition by Abbvie
  • Propeller Health in its acquisition by ResMed
  • Corium International in its acquisition by Gurnet Point Capital
  • Celenex in its acquisition by Amicus Therapeutics
  • Channel Medsystems in its merger agreement with Boston Scientific
  • Tamir Biotechnology in its sale to Orgenesis​
  • Merck in the combination of its ILÚM Health Solutions business with UPMC's Infectious Disease Connect

  • SomaLogic in its merger with Standard BioTools
  • Pardes in its going private transaction
  • Aceragen in its merger with Idera Pharmaceuticals
  • Market Access Transformation in its sale to Genesis Research
  • Klara Health in its sale to Modernizing Medicine
  • CareSignal in its sale to Lightbeam Health Solutions
  • PlushCare in its acquisition by Accolade
  • Sema4 in its acquisition of GeneDx and its de-SPAC merger with CM Life Sciences
  • ZipDrug in its acquisition by Anthem Health
  • Chinook Therapeutics in its merger with Aduro Biotech
  • Mavupharma in its acquisition by Abbvie
  • Propeller Health in its acquisition by ResMed
  • Corium International in its acquisition by Gurnet Point Capital
  • Celenex in its acquisition by Amicus Therapeutics
  • Channel Medsystems in its merger agreement with Boston Scientific
  • Tamir Biotechnology in its sale to Orgenesis​
  • Merck in the combination of its ILÚM Health Solutions business with UPMC's Infectious Disease Connect

Recognition Recognition Recognition

Recognition Recognition Recognition

Recognition
Chambers USA

2021-2023

Ranked Ethan as a leading lawyer for New York Corporate/M&A law.

The Legal 500

2022-2023

  • Has repeatedly honored Ethan for his M&A work and most recently recognized him for excellence in the area of M&A: Middle Market for transactions in the $500 million - $999 million range.
  • The Legal 500 recognized Ethan as a "Next Generation Partner (2023)."
Recognition
Chambers USA

2021-2023

Ranked Ethan as a leading lawyer for New York Corporate/M&A law.

The Legal 500

2022-2023

  • Has repeatedly honored Ethan for his M&A work and most recently recognized him for excellence in the area of M&A: Middle Market for transactions in the $500 million - $999 million range.
  • The Legal 500 recognized Ethan as a "Next Generation Partner (2023)."